MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.clgc.2014.12.003

Медицинская библиотека · Clinical genitourinary cancer · 2014

Cardiovascular mortality in patients with metastatic prostate cancer exposed to androgen deprivation therapy: a population-based study.

Gandaglia Giorgio, Sun Maxine, Popa Ioana, Schiffmann Jonas, Trudeau Vincent, Shariat Shahrokh F, Trinh Quoc-Dien, Graefen Markus, Widmer Hugues, Saad Fred, Briganti Alberto, Montorsi Francesco, Karakiewicz Pierre I

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

The aim of our study was to reexamine the prevalence of baseline cardiovascular (CV) morbidity and the rates of CV mortality in a contemporary cohort of patients with prostate cancer (PCa) exposed to androgen deprivation therapy (ADT).

MATERIALS AND

METHODS

Records of patients aged 65 years and older with metastatic PCa who received ADT were abstracted from the Surveillance, Epidemiology, and End Results-Medicare database between 1991 and 2009. The primary end points comprised 5-year CV mortality rates. Survival rates were stratified according to age and Charlson comorbidity index (CCI). Competing-risks Poisson regression methodologies were performed.

RESULTS

Overall, 9596 patients with metastatic PCa treated with ADT were identified. At baseline, 3049 patients (31.8%) had preexisting CV disease. The 5-year CV mortality rates were 9.8% and 14.8% in the overall population and in patients with preexisting CV disease, respectively. The 5-year CV mortality rates increased with advanced age and higher CCI score. In multivariate competing-risks regression analyses, age, year of diagnosis, CV comorbidities, CCI, and marital status represented independent predictors of CV mortality, after accounting for the risk of dying from other causes (all P ≤ .04). Of those, preexisting CV disease contributed to the highest risk of CV mortality. Our study is limited by its retrospective nature.

CONCLUSION

CV mortality represents a common event in patients with metastatic PCa treated with ADT. Preexisting CV disease represented the strongest risk factor.

Для цитирования: Gandaglia Giorgio, Sun Maxine, Popa Ioana, Schiffmann Jonas, Trudeau Vincent, Shariat Shahrokh F, Trinh Quoc-Dien, Graefen Markus, Widmer Hugues, Saad Fred, Briganti Alberto, Montorsi Francesco, Karakiewicz Pierre I. Cardiovascular mortality in patients with metastatic prostate cancer exposed to androgen deprivation therapy: a population-based study.. Clinical genitourinary cancer. 2014. DOI: 10.1016/j.clgc.2014.12.003.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.